Announcement
30 Sep 2025
In September 2025, the United States government announced an agreement with Pfizer to implement most-favored-nation drug pricing for American patients. The agreement secured a three-year reprieve for Pfizer from prospective tariffs on the pharmaceutical industry.
Source
Number of interventions
3
0 certainly harmful
3 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70619
194
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
2